RATE CONTROLLING MEMBRANES FOR CONTROLLED DRUG DELIVERY DEVICES

Patent №

US 6,375,978

Granted

2002-04-23

Filed 1998

Owner

INTARCIA THERAPEUTICS, INC.

+1 more

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

09213213

This invention provides rate controlling membranes for controlled drug delivery devices that are stable over time and exhibit more predictable and consistent membrane functionality. According to another aspect, the membranes have enhanced permeability. According to the invention, the rate controlling membrane of a controlled drug delivery device is subjected to a pre-treatment annealing process wherein it is subjected to an elevated temperature for a predetermined time period and subsequently cooled to ambient conditions before incorporation into a controlled drug delivery device.

PlanningA61K 9/7084A61K 9/0004A61P 1/00A61P 5/00A61P 29/00

AI classification

Planning0.90
Natural language0.02
Machine learning0.00
Evolutionary computation0.00
Speech0.00
Vision0.00
AI hardware0.00
Knowledge representation0.00

Ownership

INTARCIA THERAPEUTICS, INC.

assignment · 202520143

ALZA CORPORATION

assignment · 225460223

Assignors

KLEINER, LOTHAR W., GALE, ROBERT M., BERGGREN, RANDALL G., TONG, GILBERT T., CHEN, GUOHUA, DIONNE, KEITH E., HOUSTON, PAUL R.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC